Literature DB >> 1865045

Methylphenidate speeds evaluation processes of attention deficit disorder adolescents during a continuous performance test.

R Klorman1, J T Brumaghim, P A Fitzpatrick, A D Borgstedt.   

Abstract

Forty-six Attention Deficit Disorder (ADD) adolescents took a Continuous Performance Test (CPT) under placebo and methylphenidate (35.33 mg/day). The task required pressing one button for targets (p = .133), and another button for nontargets. Subjects displayed a strong bias to make the more frequent negative response before completely evaluating stimuli. Consistent with this assumption, subjects responded faster (by an average of 87 ms) to nontargets than to targets. Methylphenidate increased accuracy and speeded reaction times (RTs) to targets. The drug also increased the amplitude of the P3b component of the event-related potential for nontargets and shortened the latency of P3b for both targets and nontargets. These results suggest increased capacity allocation to and faster evaluation of task stimuli. Finally, the stimulant lengthened relative motor processing time (RT-P3b latency) for nontargets, a finding implying that response processing was accomplished with the benefit of earlier completion of evaluation processes for these stimuli.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1865045     DOI: 10.1007/bf00911231

Source DB:  PubMed          Journal:  J Abnorm Child Psychol        ISSN: 0091-0627


  27 in total

1.  Apparent response incompatibility effects on P3 latency depend on the task.

Authors:  A Pfefferbaum; C Christensen; J M Ford; B S Kopell
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1986-11

2.  Effects of methylphenidate on adolescents with a childhood history of attention deficit disorder: I. Clinical findings.

Authors:  R Klorman; H W Coons; A D Borgstedt
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1987-05       Impact factor: 8.829

3.  Effects of methylphenidate on normal children's mood, event-related potentials, and performance in memory scanning and vigilance.

Authors:  L J Peloquin; R Klorman
Journal:  J Abnorm Psychol       Date:  1986-02

4.  A new method for off-line removal of ocular artifact.

Authors:  G Gratton; M G Coles; E Donchin
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1983-04

5.  Effects of perceptual and cognitive difficulty on P3 and RT in young and old adults.

Authors:  J M Ford; A Pfefferbaum; J R Tinklenberg; B S Kopell
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1982-09

6.  Young adult outcome of hyperactive children who received long-term stimulant treatment.

Authors:  L Hechtman; G Weiss; T Perlman
Journal:  J Am Acad Child Psychiatry       Date:  1984-05

7.  Effects of methylphenidate in adolescents with attention deficit disorder.

Authors:  C K Varley
Journal:  J Am Acad Child Psychiatry       Date:  1983-07

8.  Normative data on revised Conners Parent and Teacher Rating Scales.

Authors:  C H Goyette; C K Conners; R F Ulrich
Journal:  J Abnorm Child Psychol       Date:  1978-06

9.  The hyperactive child at adolescence: cognitive, emotional, and social functioning.

Authors:  E Hoy; G Weiss; K Minde; N Cohen
Journal:  J Abnorm Child Psychol       Date:  1978-09

10.  Hyperactive boys almost grown up. I. Psychiatric status.

Authors:  R Gittelman; S Mannuzza; R Shenker; N Bonagura
Journal:  Arch Gen Psychiatry       Date:  1985-10
View more
  9 in total

Review 1.  The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders.

Authors:  Catharine A Winstanley
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

2.  Attention Deficit Hyperactivity Disorder.

Authors:  Bennett A. Shaywitz; Jack M. Fletcher; Sally E. Shaywitz
Journal:  Curr Treat Options Neurol       Date:  2001-05       Impact factor: 3.598

3.  Methylphenidate does not modify the impact of response frequency or stimulus sequence on performance and event-related potentials of children with attention deficit hyperactivity disorder.

Authors:  J A Smithee; R Klorman; J T Brumaghim; A D Borgstedt
Journal:  J Abnorm Child Psychol       Date:  1998-08

4.  Motor timing deficits in community and clinical boys with hyperactive behavior: the effect of methylphenidate on motor timing.

Authors:  Katya Rubia; Janet Noorloos; Anna Smith; Boudewijn Gunning; Joseph Sergeant
Journal:  J Abnorm Child Psychol       Date:  2003-06

5.  Response variability in Attention-Deficit/Hyperactivity Disorder: a neuronal and glial energetics hypothesis.

Authors:  Vivienne A Russell; Robert D Oades; Rosemary Tannock; Peter R Killeen; Judith G Auerbach; Espen B Johansen; Terje Sagvolden
Journal:  Behav Brain Funct       Date:  2006-08-23       Impact factor: 3.759

6.  Effects of methylphenidate on quantitative EEG of boys with attention-deficit hyperactivity disorder in continuous performance test.

Authors:  Dong Ho Song; Dong Won Shin; Duk In Jon; Eun Hye Ha
Journal:  Yonsei Med J       Date:  2005-02-28       Impact factor: 2.759

Review 7.  Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Ole Jakob Storebø; Erica Ramstad; Helle B Krogh; Trine Danvad Nilausen; Maria Skoog; Mathilde Holmskov; Susanne Rosendal; Camilla Groth; Frederik L Magnusson; Carlos R Moreira-Maia; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2015-11-25

8.  Prenatal PCB exposure, the corpus callosum, and response inhibition.

Authors:  Paul Stewart; Susan Fitzgerald; Jacqueline Reihman; Brooks Gump; Edward Lonky; Thomas Darvill; Jim Pagano; Peter Hauser
Journal:  Environ Health Perspect       Date:  2003-10       Impact factor: 9.031

9.  Perseveration by NK1R-/- ('knockout') mice is blunted by doses of methylphenidate that affect neither other aspects of their cognitive performance nor the behaviour of wild-type mice in the 5-Choice Continuous Performance Test.

Authors:  Katharine Pillidge; Ashley J Porter; Jared W Young; S Clare Stanford
Journal:  J Psychopharmacol       Date:  2016-04-19       Impact factor: 4.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.